Direkt zum Inhalt
Merck
  • Validation of liquid chromatographic method for analysis of lidocaine hydrochloride, dexamethasone acetate, calcium dobesilate, buthylhydroxyanisol and degradation product hydroquinone in suppositories and ointment.

Validation of liquid chromatographic method for analysis of lidocaine hydrochloride, dexamethasone acetate, calcium dobesilate, buthylhydroxyanisol and degradation product hydroquinone in suppositories and ointment.

Journal of chromatography. A (2005-09-01)
Lj Zivanovic, M Zecevic, S Markovic, S Petrovic, I Ivanovic
ZUSAMMENFASSUNG

In this paper, there was developed a sensitive, precise and accurate reversed-phase liquid chromatographic (RP-HPLC) method and validated for simultaneous determination of lidocaine hydrochloride, dexamethasone acetate (DA) and calcium dobesilate (CD) in suppositories and ointment. Also there was achieved a parallel analysis of buthylhydroxyanisol, as a preservative, and hydroquinone, as a degradation product of calcium dobesilate, present in these dosage forms. The relative standard deviation (RSD) values for all five compounds indicated a good precision and accuracy of the RP-HPLC method. Method is selective, sensitive and reproducible with good recovery values and can be applied in simultaneous determination of all mentioned compounds.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

USP
Dexamethasonacetat, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
Dexamethason-21-Acetat, ≥99%
Dexamethasonacetat, European Pharmacopoeia (EP) Reference Standard